Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy. [electronic resource]
- The Journal of antimicrobial chemotherapy Aug 2005
- 380-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0305-7453
10.1093/jac/dki235 doi
Anti-HIV Agents--administration & dosage Antiretroviral Therapy, Highly Active Atazanavir Sulfate Cohort Studies Drug Administration Schedule Female HIV Infections--blood HIV-1--drug effects Humans Male Oligopeptides--administration & dosage Pyridines--administration & dosage RNA, Viral--analysis